SlideShare a Scribd company logo
1 of 22
XIAFLEXCOLLAGENASE CLOSTRIDIUM HISTOLYTICUM
Charles Ng PharmD/MBA Candidate 2017
INDICATIONS
• Dupuytren’s contracture with a palpable cord
• Peyronie’s disease with a palpable plaque and curvature deformity of at least 30
degrees at the start of therapy
DUPUYTREN’S CONTRACTURE
• Inherited proliferative connective tissue disorder
• Flexion contracture of the hand due to a palmar fibromatosis
• Fingers bend towards the palm and cannot be fully extended
• Ring finger  middle and little fingers  thumb and index finger
• Progresses slowly and is often accompanied by some aching and
itching
• Incidence increases after 40 years old (M>W)
• Beyond 80 years old, the gender distribution is about even
PEYRONIE’S DISEASE
• Curved or bent penis
• Connective tissue disorder involving the growth of fibrous plaques in the soft
tissue of the penis
• Affects 5% of men
• Pain, abnormal curvature, erectile dysfunction, indentation, loss of girth, shortening
MECHANISM OF ACTION
• Collagenase clostridium histolyticum
• An enzyme produced by the bacterium Clostridium histolyticum that dismantles
collagen
DOSAGE FORMS & STORAGE
• Single-use glass vials containing 0.9 mg of collagenase clostridium
histolyticum as a sterile, lyophilized powder for reconstitution
• Sterile diluent for reconstitution is also
provided in a single-use glass vial
• Store in refrigerator prior to reconstitution
• Reconstituted solution can be kept at
room temperature for 1 hour or
refrigerated for 4 hours
DUPUYTREN’S CONTRACTURE DOSING &
ADMINISTRATION
• Reconstitute XIAFLEX lyophilized powder with the diluent
• Metacarpophalangeal (MCP) joint: 0.39 mL
• Proximal interphalangeal (PIP) joint: 0.31 mL
• Inject 0.58 mg into each palpable Dupuytren’s cord with a contracture
• Metacarpophalangeal (MCP) joint: 0.25 mL
• Proximal interphalangeal (PIP) joint: 0.20 mL
DUPUYTREN’S CONTRACTURE DOSING &
ADMINISTRATION
• ~24-72 hours following an injection, perform a finger extension procedure if a
contracture persists
• Injections and finger extension procedures may be administered up to 3 times per
cord at approximately 4-week intervals
• Inject up to 2 cords in the same hand per treatment visit
• Following the finger extension procedures, fit patient with a splint for use at
bedtime for up to 4 months to maintain finger extension
• Instruct patient to perform finger extension and flexion exercises several times a day
for several months
FINGER EXTENSION
• While the patient’s wrist is in the flexed position, apply moderate stretching pressure to
the injected cord by extending the finger for approximately 10-20 seconds.
• For cords affecting the PIP joint, perform the
finger extension procedure when the
MCP joint is in the flexed position
PEYRONIE’S DISEASE DOSING &
ADMINISTRATION
• Induce an erection and mark the target area in the Peyronie’s plaque to be injected
• Reconstitute XIAFLEX lyophilized powder with 0.39 mL of sterile diluent
• A treatment cycle = 2 XIAFLEX injections and a penile modeling procedure
• Inject 0.58 mg (0.25 mL) into the target plaque of a flaccid penis once, 1-3 days apart
• Perform a penile modeling procedure 1-3 days after the 2nd injection of each treatment cycle
• For each plaque causing the curvature deformity, up to 4 treatment cycles may be administered at ~ 6-
week intervals
• If the curvature deformity is less than 15 degrees then subsequent treatment cycles should not be
administered
PENILE MODELING ACTIVITIES
• Stretching
• Grasp the tip of the penis with the fingers of one hand and hold the base of the penis
with the fingers of the other
• Gently pull the penis away from the body to its full length
• Hold the stretch for 30 seconds
• Let go and allow the penis to return to its normal, unstretched length
PENILE MODELING ACTIVITIES
• Straightening
• Gently attempt to bend the shaft of the erect penis in the opposite direction of the
curve, but not so forcefully as to produce significant pain or discomfort
• Hold the penis in this more straightened position for 30 seconds, then let go
• Perform this no more than once per day, if a spontaneous erection unrelated to sexual
activity occurs
EFFICACY
• Dupuytren’s contracture
• In 2 clinical trials, 64% and 44% of the XIAFLEX treated patients,
compared to 7% and 5% of the placebo treated patients,
achieved reduction in contracture of the primary joint (MCP or
PIP) to 0°-5° after up to 3 injections
• Peyronie’s Disease
• 30% curvature change vs placebo
CONTRAINDICATIONS
• Peyronie’s plaques that involve the penile urethra due to potential risk to this
structure
• History of hypersensitivity to XIAFLEX or to collagenase used in any other
therapeutic application or application method
• Anticoagulants  increased bleeding risk
• < 18 years old?
DUPUYTREN’S CONTRACTURE: SIDE EFFECTS
• Peripheral edema: mostly swelling of injected hand
• Contusion
• Injection site hemorrhage/reaction
• Pain in extremity
• Tenderness
• Injection site swelling
• Pruritus
• Lymphadenopathy
• Skin laceration
• Lymph node pain
• Erythema
• Axillary pain
PEYRONIE’S DISEASE: SIDE EFFECTS
• Penile hematoma/swelling/pain/ecchymoses
• Blood blister
• Penile blister
• Genital pruritus
• Painful erection
• Skin discoloration
• Procedural pain
• Injection site vesicles
• Localized edema
• Dyspareunia
• Injection site pruritus
• Nodule
• Suprapubic pain
BLACK BOX WARNING
• Corporal rupture (penile fracture) and severe penile
hematoma
• Signs and symptoms
• Popping sound or sensation in an erect penis
• Sudden loss of the ability to maintain an erection
• Pain in your penis
• Purple bruising and swelling of your penis
• Difficulty urinating or blood in the urine
REMS
• Training for healthcare providers on the risks of corporal rupture and other serious
injuries to the penis, and how to properly administer XIAFLEX
• Certification in the XIAFLEX REMS Program by completing training and enrollment
in the program
• Patient Counseling about the risks of corporal rupture and other serious injuries to
the penis and the importance of patient adherence to post-injection instructions.
Healthcare Providers must give patients the Patient Counseling Tool, "What You
Need to Know About XIAFLEX Treatment for Peyronie's Disease: A Patient Guide",
after each XIAFLEX injection.
• Restricted distribution through specially certified healthcare settings (e.g.,
pharmacies, practitioners, hospitals or outpatient settings)
PATIENT EDUCATION
• Finger extension exercises  several months
• Penile modeling exercises  6 weeks
• Do not have sex or have any other sexual activity for at least 2 weeks after the
second injection of a treatment cycle with XIAFLEX and after any pain and swelling
has gone away
COST SAVINGS
• XIAFLEX Copay Program for eligible patients can cover up to $1200 for each vial of
XIAFLEX
• $2650 (2 vials)  $250
QUESTIONS????

More Related Content

What's hot

Evaluation of scortal mass
Evaluation of scortal massEvaluation of scortal mass
Evaluation of scortal massmanjil malla
 
Temporomandibular joint ankylosis and its management
Temporomandibular joint ankylosis and its managementTemporomandibular joint ankylosis and its management
Temporomandibular joint ankylosis and its managementDibya Falgoon Sarkar
 
Posterior foraminotomy for cervical disc herniation
Posterior foraminotomy for cervical disc herniationPosterior foraminotomy for cervical disc herniation
Posterior foraminotomy for cervical disc herniationProf. Dr. Mohamed Mohi Eldin
 
Ureteric injury
Ureteric injuryUreteric injury
Ureteric injurySagnik24
 
Ventral Hernia: Challenges and Choices
Ventral Hernia: Challenges and ChoicesVentral Hernia: Challenges and Choices
Ventral Hernia: Challenges and ChoicesGeorge S. Ferzli
 
Technical aspects of percutaneous vertebroplasty & kyphoplasty
Technical aspects of percutaneous vertebroplasty & kyphoplastyTechnical aspects of percutaneous vertebroplasty & kyphoplasty
Technical aspects of percutaneous vertebroplasty & kyphoplastyProf. Dr. Mohamed Mohi Eldin
 
Combined Tissue and Mesh repair for Midline Incisional Hernia
Combined Tissue and Mesh repair for Midline Incisional HerniaCombined Tissue and Mesh repair for Midline Incisional Hernia
Combined Tissue and Mesh repair for Midline Incisional HerniaKETAN VAGHOLKAR
 
Renal trauma kidney injury
Renal trauma kidney injuryRenal trauma kidney injury
Renal trauma kidney injuryRojan Adhikari
 
Urological trauma during O/G procedures
Urological trauma during O/G proceduresUrological trauma during O/G procedures
Urological trauma during O/G proceduresGAURAV NAHAR
 
Laparoscopic Ventral Hernia Repair Ppt. DR DILIP S.RAJPAL
Laparoscopic Ventral Hernia Repair Ppt. DR DILIP S.RAJPALLaparoscopic Ventral Hernia Repair Ppt. DR DILIP S.RAJPAL
Laparoscopic Ventral Hernia Repair Ppt. DR DILIP S.RAJPALdiliprajpal
 
TECTAL PLATE CYST : AN UNUSUAL PRESENTATION
TECTAL PLATE CYST : AN UNUSUAL PRESENTATION TECTAL PLATE CYST : AN UNUSUAL PRESENTATION
TECTAL PLATE CYST : AN UNUSUAL PRESENTATION WCER 2021
 

What's hot (20)

Urethral stricture
Urethral strictureUrethral stricture
Urethral stricture
 
Anatomic basis of epiduroscopy
Anatomic basis of epiduroscopyAnatomic basis of epiduroscopy
Anatomic basis of epiduroscopy
 
Evaluation of scortal mass
Evaluation of scortal massEvaluation of scortal mass
Evaluation of scortal mass
 
Facet joint injection
Facet joint injection Facet joint injection
Facet joint injection
 
Vertebroplasty and Kyphoplasty Techniques
Vertebroplasty and KyphoplastyTechniquesVertebroplasty and KyphoplastyTechniques
Vertebroplasty and Kyphoplasty Techniques
 
Sling for stress incontinence
Sling for stress incontinenceSling for stress incontinence
Sling for stress incontinence
 
Hernia
HerniaHernia
Hernia
 
Hernias
Hernias Hernias
Hernias
 
Temporomandibular joint ankylosis and its management
Temporomandibular joint ankylosis and its managementTemporomandibular joint ankylosis and its management
Temporomandibular joint ankylosis and its management
 
Posterior foraminotomy for cervical disc herniation
Posterior foraminotomy for cervical disc herniationPosterior foraminotomy for cervical disc herniation
Posterior foraminotomy for cervical disc herniation
 
Ureteric injury
Ureteric injuryUreteric injury
Ureteric injury
 
Ventral Hernia: Challenges and Choices
Ventral Hernia: Challenges and ChoicesVentral Hernia: Challenges and Choices
Ventral Hernia: Challenges and Choices
 
Technical aspects of percutaneous vertebroplasty & kyphoplasty
Technical aspects of percutaneous vertebroplasty & kyphoplastyTechnical aspects of percutaneous vertebroplasty & kyphoplasty
Technical aspects of percutaneous vertebroplasty & kyphoplasty
 
Combined Tissue and Mesh repair for Midline Incisional Hernia
Combined Tissue and Mesh repair for Midline Incisional HerniaCombined Tissue and Mesh repair for Midline Incisional Hernia
Combined Tissue and Mesh repair for Midline Incisional Hernia
 
Renal trauma kidney injury
Renal trauma kidney injuryRenal trauma kidney injury
Renal trauma kidney injury
 
Urological trauma during O/G procedures
Urological trauma during O/G proceduresUrological trauma during O/G procedures
Urological trauma during O/G procedures
 
Ureteric injury (1)
Ureteric injury (1)Ureteric injury (1)
Ureteric injury (1)
 
Laparoscopic Ventral Hernia Repair Ppt. DR DILIP S.RAJPAL
Laparoscopic Ventral Hernia Repair Ppt. DR DILIP S.RAJPALLaparoscopic Ventral Hernia Repair Ppt. DR DILIP S.RAJPAL
Laparoscopic Ventral Hernia Repair Ppt. DR DILIP S.RAJPAL
 
Endoscopic injection in VUR
Endoscopic injection in VUREndoscopic injection in VUR
Endoscopic injection in VUR
 
TECTAL PLATE CYST : AN UNUSUAL PRESENTATION
TECTAL PLATE CYST : AN UNUSUAL PRESENTATION TECTAL PLATE CYST : AN UNUSUAL PRESENTATION
TECTAL PLATE CYST : AN UNUSUAL PRESENTATION
 

Similar to Xiaflex 1

Spinal and Epidural Anaesthesia 5 1.pptx
Spinal and Epidural Anaesthesia 5 1.pptxSpinal and Epidural Anaesthesia 5 1.pptx
Spinal and Epidural Anaesthesia 5 1.pptxdeptanaesaiimsgkp
 
presentaion on perineal tear
presentaion on perineal tearpresentaion on perineal tear
presentaion on perineal tearBone Cracker Eliz
 
K. Mohan Epidural Anesthesia Presentation
K. Mohan Epidural  Anesthesia  PresentationK. Mohan Epidural  Anesthesia  Presentation
K. Mohan Epidural Anesthesia PresentationMohanK101
 
Pathology and management of compartment syndrome in orthopedics 1
Pathology and management of compartment syndrome in orthopedics 1Pathology and management of compartment syndrome in orthopedics 1
Pathology and management of compartment syndrome in orthopedics 1EnejoJoseph
 
Lecture 19 parekh non insertional and insertional achilles tears
Lecture 19 parekh non insertional and insertional achilles tearsLecture 19 parekh non insertional and insertional achilles tears
Lecture 19 parekh non insertional and insertional achilles tearsSelene G. Parekh, MD, MBA
 
15. Presentation15.pptx
15. Presentation15.pptx15. Presentation15.pptx
15. Presentation15.pptxv c
 
Diabetic foot Dr Jitesh Jain
Diabetic foot  Dr Jitesh JainDiabetic foot  Dr Jitesh Jain
Diabetic foot Dr Jitesh JainJitesh Jain
 
Osteomyelitis pp
Osteomyelitis ppOsteomyelitis pp
Osteomyelitis ppDon Chiwaya
 
epidural anaesthesia.pptx
epidural anaesthesia.pptxepidural anaesthesia.pptx
epidural anaesthesia.pptxsyedumair76
 
Pediatric instruments.pptx
Pediatric instruments.pptxPediatric instruments.pptx
Pediatric instruments.pptxssusere8f40d
 
Ganglion Impar Block- Dr Minhaj Akhter ppt.pdf
Ganglion Impar Block- Dr Minhaj Akhter ppt.pdfGanglion Impar Block- Dr Minhaj Akhter ppt.pdf
Ganglion Impar Block- Dr Minhaj Akhter ppt.pdfMinhaj Akhter
 
Interventional pain management
Interventional pain managementInterventional pain management
Interventional pain managementAnurag Aggarwal
 
Obstetrics analgesia 280617
Obstetrics analgesia 280617Obstetrics analgesia 280617
Obstetrics analgesia 280617Subrat Nayak
 
REHABILITATION OF THE BURN PATIENT by Neenu.pptx
REHABILITATION OF THE BURN PATIENT by Neenu.pptxREHABILITATION OF THE BURN PATIENT by Neenu.pptx
REHABILITATION OF THE BURN PATIENT by Neenu.pptxNEENUVARGHESE8
 

Similar to Xiaflex 1 (20)

Spinal anesthesia
Spinal anesthesiaSpinal anesthesia
Spinal anesthesia
 
De quervain’s
De quervain’sDe quervain’s
De quervain’s
 
Spinal and Epidural Anaesthesia 5 1.pptx
Spinal and Epidural Anaesthesia 5 1.pptxSpinal and Epidural Anaesthesia 5 1.pptx
Spinal and Epidural Anaesthesia 5 1.pptx
 
presentaion on perineal tear
presentaion on perineal tearpresentaion on perineal tear
presentaion on perineal tear
 
K. Mohan Epidural Anesthesia Presentation
K. Mohan Epidural  Anesthesia  PresentationK. Mohan Epidural  Anesthesia  Presentation
K. Mohan Epidural Anesthesia Presentation
 
SEPTIC ARTHRITIS.pdf
SEPTIC ARTHRITIS.pdfSEPTIC ARTHRITIS.pdf
SEPTIC ARTHRITIS.pdf
 
Pathology and management of compartment syndrome in orthopedics 1
Pathology and management of compartment syndrome in orthopedics 1Pathology and management of compartment syndrome in orthopedics 1
Pathology and management of compartment syndrome in orthopedics 1
 
Lecture 19 parekh non insertional and insertional achilles tears
Lecture 19 parekh non insertional and insertional achilles tearsLecture 19 parekh non insertional and insertional achilles tears
Lecture 19 parekh non insertional and insertional achilles tears
 
15. Presentation15.pptx
15. Presentation15.pptx15. Presentation15.pptx
15. Presentation15.pptx
 
Diabetic foot Dr Jitesh Jain
Diabetic foot  Dr Jitesh JainDiabetic foot  Dr Jitesh Jain
Diabetic foot Dr Jitesh Jain
 
Osteomyelitis pp
Osteomyelitis ppOsteomyelitis pp
Osteomyelitis pp
 
Pt in urosurgery
Pt in urosurgeryPt in urosurgery
Pt in urosurgery
 
Epidural administration
Epidural administrationEpidural administration
Epidural administration
 
epidural anaesthesia.pptx
epidural anaesthesia.pptxepidural anaesthesia.pptx
epidural anaesthesia.pptx
 
Pediatric instruments.pptx
Pediatric instruments.pptxPediatric instruments.pptx
Pediatric instruments.pptx
 
Ganglion Impar Block- Dr Minhaj Akhter ppt.pdf
Ganglion Impar Block- Dr Minhaj Akhter ppt.pdfGanglion Impar Block- Dr Minhaj Akhter ppt.pdf
Ganglion Impar Block- Dr Minhaj Akhter ppt.pdf
 
Interventional pain management
Interventional pain managementInterventional pain management
Interventional pain management
 
Labor analgesia
Labor analgesiaLabor analgesia
Labor analgesia
 
Obstetrics analgesia 280617
Obstetrics analgesia 280617Obstetrics analgesia 280617
Obstetrics analgesia 280617
 
REHABILITATION OF THE BURN PATIENT by Neenu.pptx
REHABILITATION OF THE BURN PATIENT by Neenu.pptxREHABILITATION OF THE BURN PATIENT by Neenu.pptx
REHABILITATION OF THE BURN PATIENT by Neenu.pptx
 

Xiaflex 1

  • 2. INDICATIONS • Dupuytren’s contracture with a palpable cord • Peyronie’s disease with a palpable plaque and curvature deformity of at least 30 degrees at the start of therapy
  • 3. DUPUYTREN’S CONTRACTURE • Inherited proliferative connective tissue disorder • Flexion contracture of the hand due to a palmar fibromatosis • Fingers bend towards the palm and cannot be fully extended • Ring finger  middle and little fingers  thumb and index finger • Progresses slowly and is often accompanied by some aching and itching • Incidence increases after 40 years old (M>W) • Beyond 80 years old, the gender distribution is about even
  • 4. PEYRONIE’S DISEASE • Curved or bent penis • Connective tissue disorder involving the growth of fibrous plaques in the soft tissue of the penis • Affects 5% of men • Pain, abnormal curvature, erectile dysfunction, indentation, loss of girth, shortening
  • 5. MECHANISM OF ACTION • Collagenase clostridium histolyticum • An enzyme produced by the bacterium Clostridium histolyticum that dismantles collagen
  • 6. DOSAGE FORMS & STORAGE • Single-use glass vials containing 0.9 mg of collagenase clostridium histolyticum as a sterile, lyophilized powder for reconstitution • Sterile diluent for reconstitution is also provided in a single-use glass vial • Store in refrigerator prior to reconstitution • Reconstituted solution can be kept at room temperature for 1 hour or refrigerated for 4 hours
  • 7. DUPUYTREN’S CONTRACTURE DOSING & ADMINISTRATION • Reconstitute XIAFLEX lyophilized powder with the diluent • Metacarpophalangeal (MCP) joint: 0.39 mL • Proximal interphalangeal (PIP) joint: 0.31 mL • Inject 0.58 mg into each palpable Dupuytren’s cord with a contracture • Metacarpophalangeal (MCP) joint: 0.25 mL • Proximal interphalangeal (PIP) joint: 0.20 mL
  • 8.
  • 9. DUPUYTREN’S CONTRACTURE DOSING & ADMINISTRATION • ~24-72 hours following an injection, perform a finger extension procedure if a contracture persists • Injections and finger extension procedures may be administered up to 3 times per cord at approximately 4-week intervals • Inject up to 2 cords in the same hand per treatment visit • Following the finger extension procedures, fit patient with a splint for use at bedtime for up to 4 months to maintain finger extension • Instruct patient to perform finger extension and flexion exercises several times a day for several months
  • 10. FINGER EXTENSION • While the patient’s wrist is in the flexed position, apply moderate stretching pressure to the injected cord by extending the finger for approximately 10-20 seconds. • For cords affecting the PIP joint, perform the finger extension procedure when the MCP joint is in the flexed position
  • 11. PEYRONIE’S DISEASE DOSING & ADMINISTRATION • Induce an erection and mark the target area in the Peyronie’s plaque to be injected • Reconstitute XIAFLEX lyophilized powder with 0.39 mL of sterile diluent • A treatment cycle = 2 XIAFLEX injections and a penile modeling procedure • Inject 0.58 mg (0.25 mL) into the target plaque of a flaccid penis once, 1-3 days apart • Perform a penile modeling procedure 1-3 days after the 2nd injection of each treatment cycle • For each plaque causing the curvature deformity, up to 4 treatment cycles may be administered at ~ 6- week intervals • If the curvature deformity is less than 15 degrees then subsequent treatment cycles should not be administered
  • 12. PENILE MODELING ACTIVITIES • Stretching • Grasp the tip of the penis with the fingers of one hand and hold the base of the penis with the fingers of the other • Gently pull the penis away from the body to its full length • Hold the stretch for 30 seconds • Let go and allow the penis to return to its normal, unstretched length
  • 13. PENILE MODELING ACTIVITIES • Straightening • Gently attempt to bend the shaft of the erect penis in the opposite direction of the curve, but not so forcefully as to produce significant pain or discomfort • Hold the penis in this more straightened position for 30 seconds, then let go • Perform this no more than once per day, if a spontaneous erection unrelated to sexual activity occurs
  • 14. EFFICACY • Dupuytren’s contracture • In 2 clinical trials, 64% and 44% of the XIAFLEX treated patients, compared to 7% and 5% of the placebo treated patients, achieved reduction in contracture of the primary joint (MCP or PIP) to 0°-5° after up to 3 injections • Peyronie’s Disease • 30% curvature change vs placebo
  • 15. CONTRAINDICATIONS • Peyronie’s plaques that involve the penile urethra due to potential risk to this structure • History of hypersensitivity to XIAFLEX or to collagenase used in any other therapeutic application or application method • Anticoagulants  increased bleeding risk • < 18 years old?
  • 16. DUPUYTREN’S CONTRACTURE: SIDE EFFECTS • Peripheral edema: mostly swelling of injected hand • Contusion • Injection site hemorrhage/reaction • Pain in extremity • Tenderness • Injection site swelling • Pruritus • Lymphadenopathy • Skin laceration • Lymph node pain • Erythema • Axillary pain
  • 17. PEYRONIE’S DISEASE: SIDE EFFECTS • Penile hematoma/swelling/pain/ecchymoses • Blood blister • Penile blister • Genital pruritus • Painful erection • Skin discoloration • Procedural pain • Injection site vesicles • Localized edema • Dyspareunia • Injection site pruritus • Nodule • Suprapubic pain
  • 18. BLACK BOX WARNING • Corporal rupture (penile fracture) and severe penile hematoma • Signs and symptoms • Popping sound or sensation in an erect penis • Sudden loss of the ability to maintain an erection • Pain in your penis • Purple bruising and swelling of your penis • Difficulty urinating or blood in the urine
  • 19. REMS • Training for healthcare providers on the risks of corporal rupture and other serious injuries to the penis, and how to properly administer XIAFLEX • Certification in the XIAFLEX REMS Program by completing training and enrollment in the program • Patient Counseling about the risks of corporal rupture and other serious injuries to the penis and the importance of patient adherence to post-injection instructions. Healthcare Providers must give patients the Patient Counseling Tool, "What You Need to Know About XIAFLEX Treatment for Peyronie's Disease: A Patient Guide", after each XIAFLEX injection. • Restricted distribution through specially certified healthcare settings (e.g., pharmacies, practitioners, hospitals or outpatient settings)
  • 20. PATIENT EDUCATION • Finger extension exercises  several months • Penile modeling exercises  6 weeks • Do not have sex or have any other sexual activity for at least 2 weeks after the second injection of a treatment cycle with XIAFLEX and after any pain and swelling has gone away
  • 21. COST SAVINGS • XIAFLEX Copay Program for eligible patients can cover up to $1200 for each vial of XIAFLEX • $2650 (2 vials)  $250

Editor's Notes

  1. Indications and usage: Dupuyten’s contracture: can feel the cord Not sure if medication is safe < 18 yo
  2. Dupuytren’s contracture with a palpable cord Flexion (a bending movement that decreases the angle between a segment and its proximal segment) contracture of the hand due to a palmar fibromatosis (group of benign tumors), in which the fingers bend towards the palm and cannot be fully extended (straightened). It is an inherited proliferative connective tissue disorder that involves the hand's palmar fascia. According to one study, the ring finger is the finger most commonly affected, followed by the middle and little fingers; the thumb and index finger are only rarely affected. Dupuytren's contracture progresses slowly and is often accompanied by some aching and itching. In patients with this condition, the palmar fascia (palmar aponeurosis) thickens and shortens so that the tendons connected to the fingers cannot move freely. The palmar fascia becomeshyperplastic and contracts.
  3. Specifically, scar tissue forms in the tunica albuginea, the thick sheath of tissue surrounding the corpora cavernosa  Most likely a result of overt or micro-trauma w/ abnormal healing process Genetic predisposition exists and related to scar healing cellular mechanisms; most commonly coexists w/ Dupuytren’s contracture Tx: topical verapamil (doesn’t reach plaque; injectable: 30%), vitamin E, colchicine, tamoxifen  no evidence Pde5 inhib (viagra, cialis), pentoxifylline (some evidence for pain/curvature) Usu reserved for mod-severe; obseveration for minor
  4. Pk: tmax: 10 mins
  5. Prior to reconstitution, the vials of XIAFLEX and diluent should be stored in a refrigerator at 2° to 8°C (36° to 46°F). Do not freeze. The reconstituted XIAFLEX solution can be kept at room temperature (20° to 25°C/68° to 77°F) for up to one hour or refrigerated at 2° to 8°C (36° to 46°F) for up to 4 hours prior to administration 
  6. XIAFLEX should be administered by a healthcare provider experienced in injection procedures of the hand and in the treatment of Dupuytren’s contracture.
  7. MCP or PIP
  8. While the patient’s wrist is in the flexed position, apply moderate stretching pressure to the injected cord by extending the finger for approximately 10 to 20 seconds. For cords affecting the PIP joint, perform the finger extension procedure when the MP joint is in the flexed position. If the first finger extension procedure does not result in disruption of the cord, a second and third attempt can be performed at 5- to 10-minute intervals. However, no more than 3 attempts per joint are recommended to disrupt a cord. If the cord has not been disrupted after 3 attempts, a follow-up visit may be scheduled in approximately 4 weeks. If, at that subsequent visit, the contracted cord persists, an additional XIAFLEX injection with finger extension procedures may be performed
  9. Determine if the contracture has resolved at the follow-up visit approximately 24 to 72 hours after XIAFLEX injection If a contracture remains, a passive finger extension procedure should be undertaken in an attempt to disrupt the cord Local anesthesia may be used during the finger extension procedure since the procedure can be painful for the patient
  10. XIAFLEX should be administered by a healthcare provider experienced in the treatment of male urological diseases. A single intracavernosal (base of penis) injection of 10 or 20 mcg of alprostadil (vasodilator) can be used If the curvature deformity is less than 15 degrees after the 1st, 2nd, or 3rd treatment cycle, or if further treatment is not clinically indicated, then subsequent treatment cycles should not be administered.
  11. Do it for approx 6 weeks!
  12. Pregnancy Category b Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Using XIAFLEX with certain other medicines can cause side effects. Especially tell your healthcare provider if you take: • medicines to thin your blood (anticoagulants). If you are told to stop taking a blood thinner before your XIAFLEX injection, your healthcare provider should tell you when to start taking the blood thinner again.
  13. Common Cardiovascular: Peripheral edema (Dupuytren contracture, 73% ) Dermatologic: Injection site hemorrhage (Dupuytren contracture, 38% ), Injection site reaction (Dupuytren contracture, 35% ), Pruritus (Dupuytren contracture, 15%; Peyronie disease, 4% ), Skin tenderness (Dupuytren contracture, 24% ), Swelling at injection site (Dupuytren contracture, 24% ) Hematologic: Contusion (Dupuytren contracture, up to 70% ), Ecchymosis (Peyronie disease, 14.5%; Dupuytren contracture, up to 70% ) Immunologic: Antibody development, Lymphadenopathy (Dupuytren contracture, 13% ) Musculoskeletal: Pain in limb (Dupuytren contracture, 35% ) Reproductive: Hematoma of penis (Peyronie disease, up to 65.5% ), Pain in penis (Peyronie disease, 45.4% ), Penile swelling (Peyronie disease, 55% ) Serious Musculoskeletal: Ligament injury, Finger, Rupture of tendon, Flexor (Dupuytren contracture, 0.3% ) Neurologic: Complex regional pain syndrome, Sensory neuropathy, Hand Reproductive: Hematoma of penis (Severe) (Peyronie disease, 3.7% to 6% ), Rupture of corpus cavernosum of penis (Peyronie disease, 0.5% to 0.9% )
  14. Ecchymoses: discoloration of skin
  15. Promptly evaluate signs or symptoms that reflect serious penile injury, as surgical intervention may be required.
  16. Because of the risks of corporal rupture (penile fracture) or other serious penile injury in the treatment of Peyronie’s disease, XIAFLEX is available only through the XIAFLEX REMS Program Required components of the XIAFLEX REMS Program include the following: Prescribers must be certified with the program by enrolling and completing training in the administration of XIAFLEX treatment for Peyronie’s disease. Healthcare sites must be certified with the program and ensure that XIAFLEX is only dispensed for use by certified prescribers.
  17. Do not have sex or have any other sexual activity for at least 2 weeks after the second injection of a treatment cycle with XIAFLEX and after any pain and swelling has gone away.
  18. Patient education
  19. References: https://dupuytrens-contracture.xiaflex.com/patient/patient-savings http://www.xiaflexrems.com http://www.slideshare.net/NewYorkUrologySpecialists/xiaflex-for-peyroniesdiseasealexpresentation2014